<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the present study we have used FISH to analyze the incidence of <z:mp ids='MP_0004027'>trisomy</z:mp> 8 in <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> following either a primary <z:hpo ids='HP_0005547'>myeloproliferative disorder</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>) or a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and correlated it with both the immunophenotype and the cell-cycle distribution of the leukemic blast cells </plain></SENT>
<SENT sid="1" pm="."><plain>Six of the 21 (28%) <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> studied displayed <z:mp ids='MP_0004027'>trisomy</z:mp> 8 by FISH </plain></SENT>
<SENT sid="2" pm="."><plain>The number of trisomic cells in these cases ranged from 20 to 84%, with a mean of 46 +/- 24% </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0004027'>Trisomy</z:mp> 8 was associated with a homogeneous population of leukemic cells, phenotypically characterized by CD34+/HLADR+/CD13+/CD33+/CD11b-/ CD15-/CD14- </plain></SENT>
<SENT sid="4" pm="."><plain>No significant differences were observed on the proliferative rate of cases with <z:mp ids='MP_0004027'>trisomy</z:mp> 8, as compared with blast cells from the remaining patients </plain></SENT>
<SENT sid="5" pm="."><plain>Overall, our findings suggest that in <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> secondary to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, <z:mp ids='MP_0004027'>trisomy</z:mp> 8 is associated with a blockade of myeloid maturation at an early step of the differentiation process </plain></SENT>
</text></document>